|
FAM3C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.391920E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.498100E-03 |
| Normal-vs-Stage2 |
8.416000E-01 |
| Normal-vs-Stage3 |
3.429800E-01 |
| Normal-vs-Stage4 |
7.868800E-01 |
| Stage1-vs-Stage2 |
4.912000E-01 |
| Stage1-vs-Stage3 |
4.660000E-01 |
| Stage1-vs-Stage4 |
1.999790E-01 |
| Stage2-vs-Stage3 |
7.890400E-01 |
| Stage2-vs-Stage4 |
7.737800E-01 |
| Stage3-vs-Stage4 |
4.227200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.802500E-03 |
| Normal-vs-AfricanAmerican |
2.524000E-01 |
| Normal-vs-Asian |
9.749800E-01 |
| Caucasian-vs-AfricanAmerican |
4.405000E-01 |
| Caucasian-vs-Asian |
4.266000E-01 |
| AfricanAmerican-vs-Asian |
6.679800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.00520000000126E-05 |
| Normal-vs-Female |
1.887400E-01 |
| Male-vs-Female |
1.387120E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.522500E-02 |
| Normal-vs-Extreme_Weight |
2.403200E-03 |
| Normal-vs-Obese |
5.694800E-01 |
| Normal-vs-Extreme_Obese |
2.429100E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.900400E-01 |
| Normal_Weight-vs-Obese |
2.736800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.364550E-01 |
| Extreme_Weight-vs-Obese |
1.226560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.809950E-01 |
| Obese-vs-Extreme_Obese |
1.860000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.009200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.369200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.424200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.297100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.397190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.778400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.375800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.292000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.844850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.957200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.216000E-03 |
| Normal-VS-Type2 PRCC |
4.2465000000047E-05 |
| Normal-VS-KIRP CIMP |
4.499300E-03 |
| Normal-VS-Unclassified PRCC |
6.123600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.862300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.81840000004863E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
3.527400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.571900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.332200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.082000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.629400E-04 |
| Normal-vs-N1 |
3.884200E-01 |
| Normal-vs-N2 |
8.995800E-01 |
| N0-vs-N1 |
1.203770E-03 |
| N0-vs-N2 |
1.519440E-01 |
| N1-vs-N2 |
8.532000E-01 |
|
|
